Mannitol - Potential Role in Hemodialysis Initiation for Reduction of Intra-dialytic Hypotension
Status:
Completed
Trial end date:
2018-12-01
Target enrollment:
Participant gender:
Summary
Kidney failure can result from a variety of conditions and can be temporary or permanent.
Hemodialysis is available as a replacement treatment to perform the work that the kidneys
normally do. However, the dialysis procedure can be associated with rapid changes in the
composition of the blood - this may lead to changes in blood pressure and in turn reduced
blood supply to important parts of the body. We aim to investigate if giving a medicine
(called mannitol) during dialysis may be able to reduce the frequency of these low blood
pressure events.